TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
DSGN

Design Therapeutics Inc

Healthcare · Biotechnology · —

12.10$ -1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DSGN
Line item 2019 2020 2021 2022 2023 2024 2025
– +40,473.3% +969.6% -12.7% -15.1% -13.0% -10.3%
– +40,158.9% +963.8% -13.1% -15.1% -12.8% -9.8%
– +2,989.6% +12,450.2% -91.1% -20.0% +6.4% -25.3%
– +46,771.4% +964.2% -14.0% -14.7% -12.9% -10.4%
– – +1,000.0% +913.6% +28.4% -11.8% +32.8%
– – +1,072.0% -188.9% – – –
– – +2,023.9% +29.1% – – –
– +1,181.6% -82.4% +64.1% -13.5% -16.4% +37.1%
– -37.6% +126.7% +104.0% -10.7% -12.1% +54.3%
– – – +30.9% +11.9% +11.7% +11.3%
– -43.6% +15.8% +86.7% -35.9% +12.7% +5.8%
– – – -14.3% -15.2% -12.8% -12.2%
– – – – – – –
– +0.0% +69.0% +21.3% +0.5% +1.1% +1.3%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?